LONDON — Nearly one in seven Britons who tested positive for COVID-19 continued to have symptoms for at least 12 weeks, according to a UK study released Thursday.
The Office for National Statistics said the study of over 20,000 people who had tested positive from April last year to March this year found 13.7 percent had symptoms that lasted for at least 12 weeks.
This was based on people’s self-reported symptoms of so-called “long COVID.” The list of 13 symptoms included fatigue, muscle pain and difficulty concentrating as well as loss of taste and smell.
Get The Times of Israel's Daily Edition by email and never miss our top stories
Free Sign Up
Women were more more likely (14.7 percent) to report such long-lasting symptoms than men (12.7 percent).
Those aged 35-49 were most likely to report symptoms at five weeks (25.6 percent).
Critical care staff look after a COVID-19 patient on the Christine Brown ward at King’s College Hospital in London, January 27, 2021. (Kirsty Wigglesworth/AP)
The study of UK patients was based on a random sample of 21,622 participants who tested positive from swabs and were asked about their symptoms monthly.
A control group who were unlikely to have been infected was also set up. It found they were eight times less likely to have such symptoms.
A larger survey of 1.1 million people self-reported long COVID over the four weeks ending March 6, 2021, the ONS said.
Ben Humberstone, Head of Health Analysis and Life Events at the ONS said this was its first analysis of new data and “our understanding of it and its quality will improve over time.”
Long COVID “is an emerging phenomenon that is not yet fully understood,” he added.
Britain, one of the countries worst hit by the pandemic, has recorded nearly 127,000 deaths from COVID and 4,350,266 cases.
However, the number of daily deaths and positive tests have fallen steadily amid a strong vaccination campaign.
Greetings from the Vaccination Nation
One tiny country has led the world in COVID vaccination. If Israel’s achievement makes you proud, there’s something you should know. Huge audiences have flocked to The Times of Israel recently from countries where Israel normally makes the news only because of its conflicts.
They’ve been coming here to read a very different kind of article. We’ve been the go-to site for everyone intrigued by the success story of the “Vaccination Nation.”
As ToI's Health and Science correspondent, I’ve written much of this coverage - and it’s been exhilarating to see its impact. Our journalism has inspired many articles in media outlets worldwide. I know this because international journalists have often contacted me for input.
Your support, through The Times of Israel Community, helps us to continue providing surprising, impressive stories from this small state to readers around the world. Will you join our Community today?
Thank you,
Nathan Jeffay, Health & Science Correspondent
Join our Community
Join our Community
Already a member? Sign in to stop seeing this
You’re serious. We appreciate that!
We’re really pleased that you’ve read X Times of Israel articles in the past month.
That’s why we come to work every day - to provide discerning readers like you with must-read coverage of Israel and the Jewish world.
So now we have a request. Unlike other news outlets, we haven’t put up a paywall. But as the journalism we do is costly, we invite readers for whom The Times of Israel has become important to help support our work by joining The Times of Israel Community.
For as little as $6 a month you can help support our quality journalism while enjoying The Times of Israel AD-FREE, as well as accessing exclusive content available only to Times of Israel Community members.
Join Our Community
Join Our Community
Already a member? Sign in to stop seeing this
comments